留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

不容忽视的心肌炎——来自《2021年ESC急慢性心力衰竭诊断与治疗指南》的启示

邱露虹 刘颖娴 徐希奇

邱露虹, 刘颖娴, 徐希奇. 不容忽视的心肌炎——来自《2021年ESC急慢性心力衰竭诊断与治疗指南》的启示[J]. 协和医学杂志. doi: 10.12290/xhyxzz.2022-0077
引用本文: 邱露虹, 刘颖娴, 徐希奇. 不容忽视的心肌炎——来自《2021年ESC急慢性心力衰竭诊断与治疗指南》的启示[J]. 协和医学杂志. doi: 10.12290/xhyxzz.2022-0077
QIU Luhong, LIU Yingxian, XU Xiqi. Nonnegligible Myocarditis: Insights from 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2022-0077
Citation: QIU Luhong, LIU Yingxian, XU Xiqi. Nonnegligible Myocarditis: Insights from 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2022-0077

不容忽视的心肌炎——来自《2021年ESC急慢性心力衰竭诊断与治疗指南》的启示

doi: 10.12290/xhyxzz.2022-0077
基金项目: 

国家自然科学基金(82000470)

详细信息
    通讯作者:

    徐希奇,E-mail:xuxiqi0928@163.com

  • 中图分类号: R542.2

Nonnegligible Myocarditis: Insights from 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

Funds: 

National Natural Science Foundation of China (82000470)

  • 摘要: 2021年9月欧洲心脏杂志发表了《2021年ESC急慢性心力衰竭诊断与治疗指南》,新版指南对2016年版指南作出重要更新。其中,心肌炎作为心力衰竭的一种特定临床情况应给予重点关注。本文结合我国心肌炎临床诊疗实践,对新版指南中心肌炎部分进行全面解读,以期加深临床医师对此类疾病的认识和理解。
  • [1] McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J, 2021, 42:3599-3726.
    [2] Dai H, Lotan D, Much AA, et al. Global, Regional, and National Burden of Myocarditis and Cardiomyopathy, 1990-2017[J]. Front Cardiovasc Med, 2021, 8:610989.
    [3] Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013:a systematic analysis for the Global Burden of Disease Study 2013[J].Lancet, 2015, 386:743-800.
    [4] Heymans S, Eriksson U, Lehtonen J, et al.The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy[J]. J Am Coll Cardiol, 2016, 68:2348-2364.
    [5] Merken J, Hazebroek M, Van Paassen P, et al. Immunosuppressive Therapy Improves Both Shortand Long-Term Prognosis in Patients With Virus-Negative Nonfulminant Inflammatory Cardiomyopathy[J]. Circ Heart Fail, 2018, 11:e004228.
    [6] Das M, MR Bristow, MK Chung, The Essential Vulnerability of Human Cardiac Myocytes to SARSCoV-2[J]. JACC Basic Transl Sci, 2021, 6(4):346-349.
    [7] Grün S, Schumm J, Greulich S, et al. Long-term follow-up of biopsy-proven viral myocarditis:predictors of mortality and incomplete recovery[J]. J Am Coll Cardiol, 2012, 59:1604-1615.
    [8] Yeung C, Baranchuk A. Diagnosis and Treatment of Lyme Carditis:JACC Review Topic of the Week[J]. J Am Coll Cardiol, 2019, 74:717-726.
    [9] Moslehi JJ, Salem JE, Sosman JA, et al. Increased reporting of fatal immune checkpoint inhibitorassociated myocarditis[J]. Lancet, 2018, 391:933.
    [10] Palaskas N, Lopez-Mattei J, Durand JB, et al. Immune Checkpoint Inhibitor Myocarditis:Pathophysiological Characteristics, Diagnosis, and Treatment[J]. J Am Heart Assoc, 2020, 9:e013757.
    [11] Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis:a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases[J].Eur Heart J, 2013, 34:2636-2648, 2648a- 2648d.
    [12] Staudt A, Schäper F, Stangl V, Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution[J]. Circulation, 2001, 103:2681-6.
    [13] Ammirati E, Cipriani M, Lilliu M, et al. Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis[J].Circulation, 2017, 136:529-545.
    [14] Gannon MP, Schaub E, Grines CL, et al. State of the art:Evaluation and prognostication of myocarditis using cardiac MRI[J]. J Magn Reson Imaging, 2019, 49:e122-e131.
    [15] Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy[J]. N Engl J Med, 2000, 342:1077-1084.
  • 加载中
计量
  • 文章访问数:  14
  • HTML全文浏览量:  1
  • PDF下载量:  2
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-02-23
  • 录用日期:  2022-03-17
  • 网络出版日期:  2022-04-14

目录

    /

    返回文章
    返回